Ketoconazole Induced Torsades de Pointes Without Concomitant Use of QT Interval‐Prolonging Drug
Authors:
- 8 December 2005
- journal article
- case report
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 16 (12) , 1375-1377
Abstract
Ketoconazole is not known to be proarrhythmic without concomitant use of QT interval‐prolonging drugs. We report a woman with coronary artery disease who developed a markedly prolonged QT interval and torsades de pointes (TdP) after taking ketoconazole for treatment of fungal infection. Her QT interval returned to normal upon withdrawal of ketoconazole. Genetic study did not find any mutation in her genes that encode cardiac IKr channel proteins. We postulate that by virtue of its direct blocking action on IKr, ketoconazole alone may prolong QT interval and induce TdP. This calls for attention when ketoconazole is administered to patients with risk factors for acquired long QT syndrome.Keywords
This publication has 9 references indexed in Scilit:
- Long QT syndrome caused by noncardiac drugsProgress in Cardiovascular Diseases, 2003
- Pause-dependent torsade de pointes following acute myocardial infarctionJACC, 2001
- Non-invasive testing of acquired long QT syndrome Evidence for multiple arrhythmogenic substratesCardiovascular Research, 2001
- Fluconazole-Induced Torsade de PointesAnnals of Pharmacotherapy, 2001
- A common polymorphism associated with antibiotic-induced cardiac arrhythmiaProceedings of the National Academy of Sciences, 2000
- Risk of torsades de pointes with non-cardiac drugsBMJ, 2000
- Blockade of HERG and Kv1.5 by KetoconazoleThe Journal of Pharmacology and Experimental Therapeutics, 1998
- Molecular Basis for the Lack of HERG K+ Channel Block-Related Cardiotoxicity by the H1 Receptor Blocker Cetirizine Compared with Other Second-Generation AntihistaminesMolecular Pharmacology, 1998
- Torsades de Pointes after treatment with terfenadine and ketoconazoleEuropean Heart Journal, 1992